Katarzyna Budrewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katarzyna Budrewicz has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Beata Jankowska-Polanska
Department of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland
2 shared publicationsDariusz Jagielski
Centre for Heart Diseases, 4th Military Hospital, Wroclaw, Poland
2 shared publicationsDorota Zysko
Department of Emergency Medicine, Wroclaw Medical University, Wroclaw, Poland
2 shared publicationsJarosław Madowicz
Provincial Specialist Hospital, Tychy, Poland
2 shared publicationsJoanna Wizowska
Department of Emergency Medicine, Wroclaw Medical University, Wroclaw, Poland
2 shared publicationsJolanta Zuwala-Jagiello
Department of Pharmaceutical Biochemistry, Wroclaw Medical University, Wroclaw, Poland
2 shared publications
Latest Publications
- Open Access
- 14 September 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-10
Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score
Background: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes a major health burden worldwide due to high mortality rates and hospital bed shortages. SARS-CoV-2 infection is associated with several laboratory abnormalities. We aimed to develop and validate a risk score based on simple demographic and laboratory data that could be used on admission in patients with SARS-CoV-2 infection to predict in-hospital mortality. Methods: Three cohorts of patients from different hospitals were studied consecutively (developing, validation, and prospective cohorts). The following demographic and laboratory data were obtained from medical records: sex, age, hemoglobin, mean corpuscular volume (MCV), platelets, leukocytes, sodium, potassium, creatinine, and C-reactive protein (CRP). For each variable, classification and regression tree analysis were used to establish the cut-off point(s) associated with in-hospital mortality outcome based on data from developing cohort and before they were used for analysis in the validation and prospective cohort. The covid-19 score was calculated as a sum of cut-off points associated with mortality outcome. Results: The developing, validation, and prospective cohorts included 129, 239, and 497 patients, respectively (median age, 71, 67, and 70 years, respectively). The following cut of points associated with in-hospital mortality: age > 56 years, male sex, hemoglobin < 10.55 g/dL, MCV > 92.9 fL, leukocyte count > 9.635 or < 2.64 103/µL, platelet count, < 81.49 or > 315.5 103/µL, CRP > 51.14 mg/dL, creatinine > 1.115 mg/dL, sodium < 134.7 or > 145.4 mEq/L, and potassium < 3.65 or > 6.255 mEq/L. The AUC of the covid-19 score for predicting in-hospital mortality was 0.89 (0.84–0.95), 0.850 (0.75–0.88), and 0.773 (0.731–0.816) in the developing, validation, and prospective cohorts, respectively (P < 0.001The mortality of the prospective cohort stratified on the basis of the covid-19 score was as follows: 0–2 points,4.2%; 3 points, 15%; 4 points, 29%; 5 points, 38.2%; 6 and more points, 60%. Conclusion: The covid-19 score based on simple demographic and laboratory parameters may become an easy-to-use, widely accessible, and objective tool for predicting mortality in hospitalized patients with SARS-CoV-2 infection.
- 14 September 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-10
Open AccessSimple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score
Background: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes a major health burden worldwide due to high mortality rates and hospital bed shortages. SARS-CoV-2 infection is associated with several laboratory abnormalities. We aimed to develop and validate a risk score based on simple demographic and laboratory data that could be used on admission in patients with SARS-CoV-2 infection to predict in-hospital mortality. Methods: Three cohorts of patients from different hospitals were studied consecutively (developing, validation, and prospective cohorts). The following demographic and laboratory data were obtained from medical records: sex, age, hemoglobin, mean corpuscular volume (MCV), platelets, leukocytes, sodium, potassium, creatinine, and C-reactive protein (CRP). For each variable, classification and regression tree analysis were used to establish the cut-off point(s) associated with in-hospital mortality outcome based on data from developing cohort and before they were used for analysis in the validation and prospective cohort. The covid-19 score was calculated as a sum of cut-off points associated with mortality outcome. Results: The developing, validation, and prospective cohorts included 129, 239, and 497 patients, respectively (median age, 71, 67, and 70 years, respectively). The following cut of points associated with in-hospital mortality: age > 56 years, male sex, hemoglobin < 10.55 g/dL, MCV > 92.9 fL, leukocyte count > 9.635 or < 2.64 103/µL, platelet count, < 81.49 or > 315.5 103/µL, CRP > 51.14 mg/dL, creatinine > 1.115 mg/dL, sodium < 134.7 or > 145.4 mEq/L, and potassium < 3.65 or > 6.255 mEq/L. The AUC of the covid-19 score for predicting in-hospital mortality was 0.89 (0.84–0.95), 0.850 (0.75–0.88), and 0.773 (0.731–0.816) in the developing, validation, and prospective cohorts, respectively (P < 0.001The mortality of the prospective cohort stratified on the basis of the covid-19 score was as follows: 0–2 points,4.2%; 3 points, 15%; 4 points, 29%; 5 points, 38.2%; 6 and more points, 60%. Conclusion: The covid-19 score based on simple demographic and laboratory parameters may become an easy-to-use, widely accessible, and objective tool for predicting mortality in hospitalized patients with SARS-CoV-2 infection.
- Open Access
- 14 June 2021
- Published by Springer Nature in Research Square
Simple Demographics and Laboratory Findings on Admission May Predict f In-hospital Mortality in Patients with SARS-CoV-2 Infection
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection could result in different laboratory abnormalities. The prediction of the outcome based on simple demographics and laboratory parameters could be useful for clinical purposes. The objective of the study is to develop and validate a score (Covid19-score) based on demographics and laboratory findings, performed at hospital admission in patients with a SARS-CoV-2 infection confirmed on a reverse transcriptase-polymerase chain reaction of the nasopharyngeal swab, to predict in-hospital mortality.Methods: Three cohorts of patients from three different hospitals were studied consecutively. The studied data came from patients’ electronic records. On the basis of the retrospective analysis of the mortality in the developing cohort from the first hospital the cut-off points predicting in-hospital mortality for gender, age, hemoglobin, mean corpuscular volume, platelet count, leukocyte count, sodium, potassium, creatinine level, C-reactive protein level were found and Covid19-score as a sum of points was calculated for each patient. The area under the receiver operating characteristic curve (AUC) of the Covid19-score for predicting survival to hospital discharge was counted. The Covid19-score was validated using data of patients from a second hospital. The significance of Covid19-score was confirmed on the prospective cohort of patients collected from a third hospital,Results: AUC of the Covid19-score for predicting survival to hospital discharge was 0.89 (0.84-0.95) p<0.001 in developing cohort, 0.850 (0.75-0.88) p<0.001 in validation cohort and 0.773 (0.731-0.816) p<0.001 in the prospective cohort.Conclusion: The Covid19-score is useful in predicting the clinical outcome for hospitalized patients with SARS-CoV-2 infection
- 14 June 2021
- Published by Springer Nature in Research Square
Open AccessSimple Demographics and Laboratory Findings on Admission May Predict f In-hospital Mortality in Patients with SARS-CoV-2 Infection
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection could result in different laboratory abnormalities. The prediction of the outcome based on simple demographics and laboratory parameters could be useful for clinical purposes. The objective of the study is to develop and validate a score (Covid19-score) based on demographics and laboratory findings, performed at hospital admission in patients with a SARS-CoV-2 infection confirmed on a reverse transcriptase-polymerase chain reaction of the nasopharyngeal swab, to predict in-hospital mortality.Methods: Three cohorts of patients from three different hospitals were studied consecutively. The studied data came from patients’ electronic records. On the basis of the retrospective analysis of the mortality in the developing cohort from the first hospital the cut-off points predicting in-hospital mortality for gender, age, hemoglobin, mean corpuscular volume, platelet count, leukocyte count, sodium, potassium, creatinine level, C-reactive protein level were found and Covid19-score as a sum of points was calculated for each patient. The area under the receiver operating characteristic curve (AUC) of the Covid19-score for predicting survival to hospital discharge was counted. The Covid19-score was validated using data of patients from a second hospital. The significance of Covid19-score was confirmed on the prospective cohort of patients collected from a third hospital,Results: AUC of the Covid19-score for predicting survival to hospital discharge was 0.89 (0.84-0.95) p<0.001 in developing cohort, 0.850 (0.75-0.88) p<0.001 in validation cohort and 0.773 (0.731-0.816) p<0.001 in the prospective cohort.Conclusion: The Covid19-score is useful in predicting the clinical outcome for hospitalized patients with SARS-CoV-2 infection
- Open Access
- 4 June 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (11) , 6048
The Impact of COVID-19 on Admissions and Management of Patients with Atrial Fibrillation Episodes in the Emergency Department
Background: During the COVID-19 pandemic, the number of admissions to the emergency department (ED) due to a primary diagnosis of atrial fibrillation (AF) has decreased when compared to pre-pandemic times. The principal aim of the study was to assess the frequency of SARS-CoV-2 infections and sinus rhythm restoration among patients who arrived at the ED with AF. Secondary aims included determining whether patients arriving at the ED principally due to AF delayed their presentations and whether the frequency of successful cardioversion for AF was decreased during the pandemic period. Materials and Methods: A retrospective analysis of medical records of patients admitted to two hospital EDs due to AF during July–December 2019 (pre-pandemic period) versus July–December 2020 (pandemic period) was performed. Results: During the study periods, 601 ED visits by 497 patients were made due to the primary diagnosis of AF. The patients were aged 71.2+/?13.5 years and 51.3% were male. The duration of an AF episode before the ED admission was 10 h (4.5–30 h) during the pandemic period vs. 5 h (3–24 h) during the non-pandemic period (p = 0.001). A shorter duration of the AF episode before ED admission was associated with the successful restoration of the sinus rhythm. During the pandemic period, among patients with short-lasting AF who were not treated with Phenazolinum, the restoration of the sinus rhythm was more frequent in the Copernicus Memorial Hospital than in the University Hospital (p = 0.026). A positive SARS-CoV-2 test was found in 5 (1%) patients, while 2 other patients (0.5%) had a prior diagnosis of COVID-19 disease noted in their medical history. Conclusions: 1. The number of AF episodes treated in these two EDs was lower during the pandemic than non-pandemic period. 2. The patients with AF appeared at the ED later after AF onset in the pandemic period. 3. Successful cardioversion of atrial fibrillation was more frequent during the pre-pandemic period in one of the two hospitals. 4. A difference of approaches to the treatment of short-lasting AF episodes between EDs during the pandemic period may exist between these two EDs. 5. The patients with SARS-CoV-2 infection during the second wave of the COVID-19 pandemic constituted a small percentage of the patients admitted to EDs due to an AF episode.
- 4 June 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (11) , 6048
Open AccessThe Impact of COVID-19 on Admissions and Management of Patients with Atrial Fibrillation Episodes in the Emergency Department
Background: During the COVID-19 pandemic, the number of admissions to the emergency department (ED) due to a primary diagnosis of atrial fibrillation (AF) has decreased when compared to pre-pandemic times. The principal aim of the study was to assess the frequency of SARS-CoV-2 infections and sinus rhythm restoration among patients who arrived at the ED with AF. Secondary aims included determining whether patients arriving at the ED principally due to AF delayed their presentations and whether the frequency of successful cardioversion for AF was decreased during the pandemic period. Materials and Methods: A retrospective analysis of medical records of patients admitted to two hospital EDs due to AF during July–December 2019 (pre-pandemic period) versus July–December 2020 (pandemic period) was performed. Results: During the study periods, 601 ED visits by 497 patients were made due to the primary diagnosis of AF. The patients were aged 71.2+/?13.5 years and 51.3% were male. The duration of an AF episode before the ED admission was 10 h (4.5–30 h) during the pandemic period vs. 5 h (3–24 h) during the non-pandemic period (p = 0.001). A shorter duration of the AF episode before ED admission was associated with the successful restoration of the sinus rhythm. During the pandemic period, among patients with short-lasting AF who were not treated with Phenazolinum, the restoration of the sinus rhythm was more frequent in the Copernicus Memorial Hospital than in the University Hospital (p = 0.026). A positive SARS-CoV-2 test was found in 5 (1%) patients, while 2 other patients (0.5%) had a prior diagnosis of COVID-19 disease noted in their medical history. Conclusions: 1. The number of AF episodes treated in these two EDs was lower during the pandemic than non-pandemic period. 2. The patients with AF appeared at the ED later after AF onset in the pandemic period. 3. Successful cardioversion of atrial fibrillation was more frequent during the pre-pandemic period in one of the two hospitals. 4. A difference of approaches to the treatment of short-lasting AF episodes between EDs during the pandemic period may exist between these two EDs. 5. The patients with SARS-CoV-2 infection during the second wave of the COVID-19 pandemic constituted a small percentage of the patients admitted to EDs due to an AF episode.
- 1 April 2019
- Published by Borgis Sp. z o.o. in Postępy Nauk Medycznych
- Vol. 32 (2)
Endoscopic and histologic findings in patients referred for endoscopy by general practitioners in 2008-2013
Introduction. Patients with gastroesophageal reflux disease who did not improve with proton pomp inhibitors are at risk of serious diseases and should undergo endoscopy. Aim. The aim of the study was to present endoscopic and histopathologic findings in the esophagus in patients referred by a general practitioners to the Department of Gastrointestinal and General Surgery, Wroclaw Medical University in years 2008-2013 with initial diagnosis of GERD, in which the family doctor did not achieve the expected results of the empirical treatment with proton pump inhibitors. Material and methods. The clinical material included 122 patients (51 women and 71 men) aged 55.8 ± 14.1 referred for endoscopy by their general practitioners because of a lack of improvement after empirical treatment. Retrospective analysis of the endoscopic and histologic finding was performed. Results. The most prevalent diagnosis was hernia hiatus oesophagi (n = 41; 33.6%) and the least Barrett’s esophagus (n = 6; 4.9%). In men the most prevalent diagnosis was adenocarcinoma (n = 22; 31.0%) and in women hiatal hernia (n = 24; 47.1%). Near 60% patients were found to have histopathologic abnormalities. The most common finding was oesophageal cancer (n = 22; 18.0%) and the least dysplasia (n = 7; 5.7%). In men the most prevalent diagnosis was adenocarcinoma (n = 21; 29.6%) and in women esophagitis (n = 8; 11.3%) and Barrett’s esophagus (n = 8; 11.3%). Conclusions. 1. Near one quarter of patients with ineffective GERD symptoms treatment, who were referred for endoscopy by family practitioners, has serious endoscopic and histologic diagnosis. 2. Male gender and age above 52 years are risk factors for esophageal adenocarcinoma. 3. GERD complications are more common in men and benign complications prevail among women.
- 1 April 2019
- Published by Borgis Sp. z o.o. in Postępy Nauk Medycznych
- Vol. 32 (2)
Endoscopic and histologic findings in patients referred for endoscopy by general practitioners in 2008-2013
Introduction. Patients with gastroesophageal reflux disease who did not improve with proton pomp inhibitors are at risk of serious diseases and should undergo endoscopy. Aim. The aim of the study was to present endoscopic and histopathologic findings in the esophagus in patients referred by a general practitioners to the Department of Gastrointestinal and General Surgery, Wroclaw Medical University in years 2008-2013 with initial diagnosis of GERD, in which the family doctor did not achieve the expected results of the empirical treatment with proton pump inhibitors. Material and methods. The clinical material included 122 patients (51 women and 71 men) aged 55.8 ± 14.1 referred for endoscopy by their general practitioners because of a lack of improvement after empirical treatment. Retrospective analysis of the endoscopic and histologic finding was performed. Results. The most prevalent diagnosis was hernia hiatus oesophagi (n = 41; 33.6%) and the least Barrett’s esophagus (n = 6; 4.9%). In men the most prevalent diagnosis was adenocarcinoma (n = 22; 31.0%) and in women hiatal hernia (n = 24; 47.1%). Near 60% patients were found to have histopathologic abnormalities. The most common finding was oesophageal cancer (n = 22; 18.0%) and the least dysplasia (n = 7; 5.7%). In men the most prevalent diagnosis was adenocarcinoma (n = 21; 29.6%) and in women esophagitis (n = 8; 11.3%) and Barrett’s esophagus (n = 8; 11.3%). Conclusions. 1. Near one quarter of patients with ineffective GERD symptoms treatment, who were referred for endoscopy by family practitioners, has serious endoscopic and histologic diagnosis. 2. Male gender and age above 52 years are risk factors for esophageal adenocarcinoma. 3. GERD complications are more common in men and benign complications prevail among women.